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Abstract 
As women enter menopause at mid-life, estrogen production ceases and its many beneficial 
effects on cardiovascular health are lost whereby the age-related risk of cardiovascular 
disease is accelerated. Estrogen acts via estrogen receptors and can activate the estrogen 
response element leading to upregulation of a number of proteins of importance for vascular 
health, including the vasodilator and anti-atherogenic enzyme endothelial nitric oxide 
synthase and angiogenic factors. Hormone replacement therapy can to some extent counteract 
the loss of estrogen although studies have shown that such treatment may only be effective if 
initiated soon after menopause, the so-called timing hypothesis. An attractive alternative to 
hormone therapy is regular physical activity, as it is known that exercise induces many of the 
same cardiovascular health protective effects as estrogen. Nevertheless, results from studies 
on the effect of physical activity on vascular function and cardiovascular health are 
inconsistent, with some studies showing a lack of effect of a physical activity program and 
others showing a beneficial effect. The reason for this divergence is unclear but here we 
explore whether there may be a timing aspect also for exercise training, the exercise timing 
hypothesis, where initiation of exercise interventions soon after menopause may be more 
effective than initiation many years after. The possibility that estrogen related receptor- and 
oxidative stress may play a role for such a timing effect are discussed. 
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Introduction 
The onset of menopause, with a consequent loss of estrogen, is associated with an increased 
risk of cardiovascular events, in part due to impaired vascular endothelial function, a rise in 
blood pressure and an increased risk of atherosclerosis (Mozaffarian et al., 2015). Hormone 
replacement therapy was initially thought to counteract the decline in cardiovascular health in 
women after menopause (Grady et al., 1992) but studies such as The Women’s Health 
initiative reported an increased risk of cardiovascular events in women receiving hormone 
treatment, with the risk being most pronounced in women who were many years beyond 
menopause (Naftolin et al., 2004; Rossow et al., 2010). More recent studies; The Kronos 
Early Estrogen and Prevention Study (KEEPS) (Miller et al., 2009) and The Early Versus 
Late Intervention Trial (ELITE) (Hodis et al., 2016) have shown that hormone therapy may 
have beneficial effects on cardiovascular health if treatment is begun within the first six years 
of menopause but not in late menopausal women. This time dependent effect of treatment is 
referred to as “The timing hypothesis”. The mechanism underlying the timing hypothesis has 
not yet been fully elucidated. 
The main question we raise in the current symposium review is whether there may be a 
similar aspect of timing of exercise training after menopause; “The exercise timing 
hypothesis”. Regular exercise training is clearly beneficial for men at all ages and numerous 
studies have shown that men up to very old age profit from training in terms of vascular and 
cardiac function (Schmidt et al., 2014; Vorup et al., 2017). In women at older age however, 
there is limited and conflicting data on a positive effect of exercise training on cardiac (Spina 
et al., 1993; Egelund et al., 2017) and vascular function (Pierce et al., 2011a; Moreau et al., 
2013; Nyberg et al., 2016; Seidelin et al., 2017). Here we propose that greater improvements 
in vascular function may be achieved in women if training is initiated at middle age, soon 
after menopause, as opposed to many years (5-10 years) after menopause. The rationale 
behind this thinking stems from observations in studies on women at or beyond middle age, 
where some studies show no improvement in cardiovascular function after a period of 
physical activity (Spina et al., 1993; Pierce et al., 2011b; Moreau et al., 2013) whereas others 
show a substantial improvement (Nyberg et al., 2014; 2016; Egelund et al., 2017). One of the 
differences in design between these studies was the age of the postmenopausal women, where 
vascular benefits were achieved in recent (Nyberg et al., 2014; 2016) but not late (Pierce et 
al., 2011a; Moreau et al., 2013) postmenopausal women. Moreover, published and 
unpublished data from our group indicates that the estrogen related receptor-, as assessed in 
 This article is protected by copyright. All rights reserved. 3 
whole muscle, may be involved in adaptations in the recent but potentially not in the late 
postmenopausal period (Nyberg et al., 2016); Gliemann & Hellsten, unpublished 
observations). As discussed further below, it is worth noticing that evidence is limited to a 
few studies and that the subjects and the methodologies used differ between the studies.  A 
third potential reason for a timing effect could be the same as indicated in studies on hormone 
replacement therapy (Hodis et al., 2016), that prevention of a decline in cardiovascular health 
may be more easily achieved than reversal of already established detrimental changes in the 
vascular system. Below we will discuss the role of exercise training in attenuating the 
detrimental impact of estrogen loss, address the idea that timing of exercise training after 
menopause may be of importance and that estrogen related receptor- and oxidative stress 
could be underlying mechanisms. 
Effects of estrogen on vascular function 
A thorough overview on the effect of estrogen on vascular endothelial function is provided by 
Novella et al. in this same symposia series (publication office; please insert ref once 
available) in this symposia review collection on Vascular function, exercise and estrogen, 
therefore, only a brief account of the estrogen pathways and effects is provided here. 
Estrogen can exert both genomic and non-genomic effects in the cardiovascular system and 
contributes to the regulation of vascular tone, vascular remodeling and protection against 
atherosclerotic plaque buildup.  Estrogen mediates its effects by acting on the estrogen 
receptors ERα, ERβ and G protein coupled estrogen receptor 1 (GPER1, figure 1). These 
receptors are located in skeletal muscle (Wiik et al., 2009a) and in endothelial and smooth 
muscle cells of the vascular wall (Haas et al. 2007).  The genomic effect of estrogen is 
mediated primarily by activation of intracellular ERα or ERβ leading to translocation to the 
cell nucleus where the estrogen-estrogen receptor complex acts as a transcription factor 
regulating gene expression. Part of this effect is via binding to the estrogen response element 
(ERE). Activation of ERα located at the plasma membrane, activates the 
phosphatidylinositol-3-OH kinase (PI3K) and mitogen activated protein kinase (MAPK) 
pathway leading to eNOS activation (Lantin-Hermoso et al., 1997; Chen et al., 1999; 
Simoncini et al., 2000). In the cardiovascular system, ERα has been described to be the 
primary receptor and most studies on the role of estrogen in the cardiovascular system have 
examined the importance of ERα with less being known about the role of ERβ. The 
expression of ERα assessed in venous endothelial cells fluctuates with the estrogen levels 
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during the menstrual cycle and the level of expression in older postmenopausal women is 
similar to that of the low estrogen period (early follicular phase) of the menstrual cycle 
(Gavin et al., 2009; Hellsten & Gliemann, 2018). 
The estrogen receptor GPER, a G protein coupled receptor, is located at the cell-membrane 
and is primarily involved in the non-genomic pathway. Activation of GPER by estrogen leads 
to activation of cellular pathways including endothelial nitric oxide synthase (eNOS) and 
inhibition of smooth muscle cell proliferation (Li et al., 2013). Studies have suggested that 
GPER is the main receptor responsible for the vasodilator effect of estrogen (Sudhir et al., 
1995; Shaw et al., 2000) via eNOS activation (Meyer et al., 2010) and via an endothelium 
independent pathway (Yu et al., 2011). However, further work is required to determine the 
specific physiological roles of the different estrogen receptors. 
 
The timing hypothesis and underlying mechanisms 
After the initial studies showing a potential detrimental effect of hormone replacement 
therapy on cardiovascular health primarily in late postmenopausal women, studies were 
conducted to elucidate the influence of time after menopause. In the ELITE study, the effect 
of hormone replacement therapy was compared in women within 6 years after menopause 
with women treated after more than 10 years post menopause (Hodis et al., 2016).  The study 
showed that the progression of atherosclerotic plaque build-up was lower in the early 
compared to the late menopausal women (Hodis et al., 2016). A similar finding was made in 
non-human primates subjected to experimentally induced menopause where a lack of effect 
of estrogen treatment was observed once atherosclerotic plaques had been established 
(Mikkola & Clarkson, 2002). In fact, late treatment increased the risk of plaque rupture and 
thrombosis (Mikkola & Clarkson, 2002). Timing of estrogen treatment may also affect low-
grade inflammation. Novella and co-workers cultured uterine arteries from postmenopausal 
women and found that incubation with estrogen induced a pro-inflammatory profile in the 
arteries from women who were more than five years after menopause, whereas in arteries 
from women closer to menopause, an anti-inflammatory effect was observed (Novella et al., 
2012).  
In relation to the above, it is noteworthy that estrogen treatment has been shown to improve 
vascular function, assessed as brachial artery flow mediated dilation, in older post-
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menopausal women (Moreau et al., 2013). This discrepancy underlines the complexity of the 
role of estrogen in the cardiovascular system in women after menopause.  
Mechanistic evidence explaining the importance of early versus late treatment is scarce but 
there is data to suggest that ERα density is lowered (Gavin et al., 2009) and ERβ increased 
(Novella et al., 2012) with age. ERα density has also been found to be higher in arteries with 
already established signs of atherosclerosis (Losordo et al., 1994) and, in addition to changes 
in receptor expression, the function of ERα may be altered due to methylation of the 
promotor region (Post et al., 1999). At the cellular level, such estrogen receptor changes may 
reduce or completely abolish the effects of estrogen on vascular health.  
A parallel to the timing hypothesis of estrogen in the cardiovascular system is the observation 
that insulin stimulated glucose uptake into skeletal muscle is improved by estrogen therapy in 
early but not late postmenopausal women (Pereira et al., 2015). On the mechanistic side, 
skeletal muscle of the late postmenopausal women had fewer ERα and ERβ receptors than 
recent postmenopausal women and estrogen treatment was found to increase PGC-1α and 
AMPK expression only in the recent postmenopausal women (Park et al., 2017).  Such data 
further support a role of alterations in estrogen receptor distribution and/or function in the 
timing aspect. 
With regards to the timing of exercise training, it is plausible that alterations in estrogen 
levels and estrogen receptors with time after menopause influence the effect of exercise in 
postmenopausal women. However, timing may also be related to a secondary effect, where 
detrimental changes in atherosclerosis and vascular function due to the loss of estrogen 
reduce the efficacy of training. There is evidence to suggest that it is more difficult to achieve 
reversal of already established cardiometabolic diseases than to prevent or delay early 
changes. The age-associated changes in low grade inflammation and increased oxidative 
stress in the cardiovascular system are likely to counteract exercise training induced 
improvements in the antithrombotic and vasodilatory effects of NO. In fact, the finding that 
estrogen in post-menopausal women improves flow mediated dilation and allows for 
improvements with exercise training has been suggested to be related to an estrogen induced 
reduction in oxidative stress (Moreau et al., 2013).  
Nevertheless, more direct effects of estrogen receptors should be considered. In a study on 
muscle cell cultures it was observed that muscle contraction, in the absence of estrogen, could 
activate the estrogen response element (Wiik et al., 2009b), an effect which may have been 
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due to activation of one of the estrogen receptors, or of the estrogen related receptor-. Thus, 
it is plausible that muscle contraction directly can induce similar effects as estrogen. The 
finding that estrogen is required for training effects in older postmenopausal women but not 
in younger, could also suggest a direct coupling between muscle contraction and the estrogen 
receptors but the mechanism of such a coupling is unclear. These aspects are further 
discussed in the sections below. 
Effects of exercise training on vascular function in mid-life women 
It is well established that physical activity and exercise training improves cardiovascular 
function in men and cross sectional data shows that vascular function is better in life-long 
physically active older men compared to sedentary older men and that vascular function of 
active older men are comparable to that of young healthy men (Pierce et al., 2011b; Nyberg 
et al., 2012; Green et al., 2017).  
In contrast to the relatively well documented effect of exercise training in men, there is a 
paucity of studies in the literature related to cardiovascular function in women. Please see the 
thorough overview provided by Seals et al. from the same symposia series (publication 
office; please insert ref once available). Only a few studies have been published with data on 
how vascular function develops as function of age in women and the effects of exercise 
training on vascular function in women is controversial. It has been shown that flow mediated 
dilation is improved after a period of exercise training in aged men but not in age-matched 
post-menopausal women (Pierce et al., 2011a) and a cross sectional study reported that life-
long trained post-menopausal women express a similar  vascular dysfunction as their 
sedentary counterparts (Santos-Parker et al., 2017). The explanation for these observations 
remain largely unknown but attempts have been made to elucidate the underlying 
mechanisms; when exercise training is combined with estradiol supplementation (oral or 
transdermal), post-menopausal women are able to improve their vascular function to the same 
extent as age-matched men and pre-menopausal women (Moreau et al., 2013). In addition, 
positive effects of exercise training in post-menopausal women are apparent when free 
radicals are scavenged by infusion of ascorbic acid suggesting that the underlying mechanism 
of the combined effect of estrogen and exercise training are associated with the antioxidant 
properties of estrogen (Moreau et al., 2013). Supplementation of tetrahydrobiopterin (BH4), 
an essential co-factor for eNOS activity, rescues vascular function in post-menopausal 
women (Moreau et al., 2012) and collectively, this suggest that mechanisms related to NO 
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bioavailability are key for the response to exercise training in post-menopausal women. 
However, further evidence for the cellular mechanism behind the apparent lack of effect of 
exercise training on vascular function after the menopausal transition is warranted. Contrary 
to these findings, recent studies have shown that vascular function is improved in both late 
pre- and recent post-menopausal women after a period of intense exercise training when 
vascular function is tested by femoral arterial infusion of acetylcholine and epoprostenol 
(Nyberg et al., 2016). Circulating markers of systemic inflammation and atherosclerosis; the 
soluble intercellular adhesion molecule-1 and soluble vascular adhesion molecule-1, have 
also been shown to be reduced to the same extent in pre- and recent post-menopausal women 
(Nyberg et al., 2014). In addition, training-induced adaptations in cardiac function were 
similar in pre- and recent post-menopausal women and exercise training lowered platelet 
reactivity in both groups (Egelund et al., 2017; Lundberg Slingsby et al., 2017). Collectively, 
these findings indicate that the trainability of the cardiovascular system is preserved in the 
early postmenopausal phase and combined with the observations that life-long trained post-
menopausal women may or may not have better vascular function than their sedentary 
counterparts (see figure 2) indicate the importance of future studies that clearly show when or 
if the trainability diminishes after menopause.  
The idea of a timing hypothesis for exercise training in postmenopausal women 
In this brief review we bring forth the exercise timing hypothesis related to when exercise is 
initiated after menopause. This hypothesis is similar to the previously discussed timing 
hypothesis on estradiol supplementation and suggests that the positive effects of exercise are 
only present if regular physical activity is initiated in the early post-menopausal phase. The 
exercise timing hypothesis is based on the combined observations that vascular function in 
late post-menopausal women is not improved after a period of exercise training (Moreau et 
al., 2013), that habitually active post-menopausal women have the same impaired vascular 
function as their sedentary counterparts (Santos-Parker et al., 2017) while vascular function is 
improved to the same extent, or even better, in recent-menopausal compared to late pre-
menopausal women (Nyberg et al., 2014; 2016).  
Thus, it is suggested that exercise training is more effective in improving vascular function in 
the early post-menopausal phase and the effects of exercise training will either decrease 
gradually as function of years after menopause or cease more abruptly at a certain, but yet 
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unknown menopausal age. Below we discuss mechanisms which could be the underlying 
cause of this phenomenon. 
Estrogen related receptor- as key element for training adaptations 
From a molecular perspective, one explanation for the difference in response to exercise 
training in early- and late-postmenopausal women reside in the molecular signals that are 
initiated by either muscle activity or estrogen. As described in detail above, estrogen acts by 
binding to the estrogen receptors that subsequently cause transcriptional activation via the 
estrogen response element (Ciana et al., 2003). Estrogen related receptors are orphan nuclear 
receptors similar to estrogen receptors, but which do not bind estrogen (Giguère et al., 1988). 
Instead, estrogen related receptors are activated by a mitogen-activated protein kinase 
(MAPK) and peroxisome proliferator-activated receptor gamma coactivator 1 (PGC1) 
dependent pathway  (Ariazi et al., 2007; Wiik et al., 2009b) and, similarly to the estrogen 
receptors, estrogen related receptors are able to cause transcriptional activation via estrogen 
response element (Ciana et al., 2003). Exercise training also activates the MAPK and PGC1 
pathway and muscle contraction of cultured skeletal muscle cells have been shown to activate 
estrogen response element via a MAPK dependent pathway (Wiik et al., 2009b). Moreover, 
estrogen related receptors have been shown to regulate mitochondrial biogenesis and to be 
essential for exercise tolerance and muscle fitness in animal models (Schreiber et al., 2004; 
Perry et al., 2014).  In humans, acute exercise increases mRNA levels of estrogen related 
receptors in the skeletal muscle (Cartoni et al., 2005). Collectively, both estrogen and 
exercise can activate pathways to promote gene transcription and non-genomic activation of 
enzymes involved in vascular function. This includes upregulation and activation of eNOS 
but also upregulation of the mitochondrial antioxidant superoxide dismutase 2 (Huang et al., 
1997; Sumi & Ignarro, 2003). Since NO is an essential molecule for maintaining optimal 
vascular function, both the estrogenic and non-estrogenic (i.e. exercise) pathway is likely to 
be involved in governing vascular function in women  (Craige et al., 2016).  
Until the menopausal transition, estrogen response element can be activated both by estrogen 
via estrogen receptors (Ciana et al., 2003) and by exercise, potentially via estrogen related 
receptor- (Wiik et al., 2009b) and these pathways, with their link to NO bioavailability 
(Huang et al., 1997; Sumi & Ignarro, 2003), are likely central mechanisms underlying the 
protective effects of estrogen and exercise on the cardiovascular system (figure 1). The 
important point here is that, after the cessation of estrogen production with menopause, 
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estrogen response element can still be activated through muscle activity leading to changes 
such as increased eNOS expression and activation, via the estrogen related receptor- 
pathway. This clearly emphasizes the relevance of exercise training at menopause for 
maintaining or improving vascular function. In support of this theory, it has been shown that 
a period of exercise training increases the expression of estrogen related receptor- in recent 
post-menopausal women, but not in pre-menopausal women, in parallel with a  greater 
increase in the eNOS expression in the recent post-menopausal women, suggesting that 
activation of the estrogen related receptor- pathway is of greater importance for the training 
adaptations in the recent postmenopausal group and that the presence of estrogen in the 
premenopausal group may limit the estrogen related receptor- pathway (Nyberg et al., 
2017). Unpublished observations from our lab also indicate that the expression of estrogen 
related receptor-is reduced as function of years after menopause in sedentary women (see 
figure 3). This could potentially explain the finding that late-postmenopausal women are 
unable to improve their vascular function by exercise training (Moreau et al., 2013). 
Exploratory analysis from the Moreau et al. 2013 study indicated that improvements in 
endothelial function after exercise training was observed only in prior hormone replacement 
therapy users but not in the post-menopausal women who had never used hormone 
replacement therapy which could support that the duration where the estrogen response 
element is not activated via estrogen receptors is critical for the outcome of a training 
intervention (Moreau et al., 2013). On this basis, we propose that, although it is never too late 
to begin training, it may be most beneficial for women to begin exercise training around the 
menopausal transition.  
Age related vascular impairment- the hard way back 
Another aspect of the observation that exercise training does not improve vascular function in 
late-postmenopausal women is that impairments of the vasculature beyond a point, 
particularly of the endothelial cells, becomes progressively difficult to reverse (Francis & 
Pierce, 2011). In line with this, it has been shown that the progression of atherosclerosis after 
menopause can be offset in early, but not late, post-menopausal women by oral estradiol 
supplementation (Hodis et al., 2016). Atherosclerosis is initiated by the response of the 
endothelial cells to insult caused by a prolonged period of suboptimal conditions which may 
arise from lifestyle factors including hypertension, hyperlipidemia, hyperglycemia, free 
radicals and abnormal shear stress (Lusis, 2000). The pathogenesis of atherosclerosis is 
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multifactorial and progresses from functional to structural alterations. For detailed review see 
(Francis & Pierce, 2011). In short, initial endothelial injury impairs endothelial function and 
causes increased endothelial permeability that allows for accumulation of low-density 
lipoproteins within the tunica intima of the arterial vessel wall. The endothelial cell then 
releases inflammatory, aggregatory and adhesion molecules. Leukocytes are infiltrated in the 
vessel wall and the formation of a fibrous cap and smooth muscle cell migration and 
proliferation occurs when atherosclerosis is most progressed. The reversal of atherosclerosis 
becomes a particular difficult process once structural changes has occurred, and this could 
very well coincide by the time early menopause translate into late menopause. The reversal 
includes removal of lipids and necrotic material, regression of smooth muscle cells and 
restoration of endothelial and smooth muscle function (Francis & Pierce, 2011). Collectively, 
once manifested, reversal of more severe atherosclerosis requires substantial time and is not 
easily achieved and therefore promoting delay of atherosclerosis and plaque build-up by 
initiation of physical activity earlier on in life is likely to be beneficial. It should, 
nevertheless, be pointed out that other lifestyle factors as well as genetics influence 
atherosclerosis thus not all postmenopausal women will show severe atherosclerosis even 
with a sedentary life-style.  
Imbalance between formation and removal of reactive oxygen species with advancing age 
and exercise 
The production of reactive oxygen species (ROS) increases with advancing age while the 
endogenous antioxidant system is reduced, collectively leading to increased oxidative stress 
(Stadtman, 2001). The effects of ROS on substances important for optimal vascular function 
are multifactorial (Assar et al., 2013)). First, ROS readily scavenge NO by reacting with NO 
to form peroxynitrite (Schulz et al., 2008; Seals et al., 2011). Secondly, ROS cause 
uncoupling of the homodimeric enzyme eNOS resulting in production of superoxide at the 
expense of NO production (Higashi et al., 2002; Förstermann, 2006). Thirdly, free radicals 
readily inactivate prostacyclin synthase whereby the substrate for prostacyclin formation is 
shifted toward synthesis of the vasoconstrictor thromboxane via thromboxane synthase 
(Gluais et al., 2005). A role for estrogen in oxidative stress has been demonstrated by 
infusion of either the antioxidant ascorbic acid or the prostanoid inhibitor indomethacin 
restoring acetylcholine induced vasodilation in ovariectomized women indicating that both 
free radicals and prostanoid derived vasoconstrictors are involved in the impaired vascular 
function caused by estrogen deprivation (Virdis et al., 2000). Since menopause is also 
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associated with a reduction of the endogenous antioxidant enzymes in both endothelial cells 
and erythrocytes (Bellanti et al., 2013; Liu et al., 2014), this could in theory counteract any 
exercise training induced improvement of the enzymatic production of vasodilators.  
Exercise increases the formation of ROS in skeletal muscles which are likely to be important 
signals mediating the training effect (Davies et al., 1982; Silveira et al., 2003; Hellsten et al., 
2007) and in a healthy system, excessive ROS formation during exercise is balanced by 
endogenous antioxidants in the skeletal muscle cells and the vascular wall. However, if the 
endogenous antioxidant defense is reduced, as observed with both aging and menopause 
(Bellanti et al., 2013; Liu et al., 2014), it is likely that the formation of ROS is inadequately 
matched by antioxidants and the ROS levels may become detrimental. The endogenous 
antioxidant system has been shown to be increased after a period of exercise training in both 
young and aged men (Gliemann et al., 2013; 2014) but the effects of exercise training on 
endogenous antioxidants across the menopausal transition is unknown. Together, it could be 
speculated that exercise training should be initiated before the endogenous antioxidants starts 
to decline as a consequence of estrogen deprivation in order to enhance the antioxidant 
system before the oxidative stress becomes too large.  
Summary and important considerations 
In summary, the underlying mechanism that give raise to the exercise timing hypothesis may 
reside in i) a gradual decline in expression of estrogen related receptor-or other molecular 
changes causing the exercise signal to be lost. ii) a functional to structural progression of 
atherosclerosis which becomes difficult to reverse and/or iii) an impaired antioxidant defense 
system that causes exercise derived ROS to be less of an exercise signal molecule and more a 
detrimental oxidative stressor. The estrogen related receptor- theory is interesting and 
potentially important and should be further explored. However, in general, further studies 
including both cell, animal and human models are clearly needed to confirm existence of the 
exercise timing hypothesis and the underlying mechanisms.   
It is important to note that not all observations in the literature support the concept of the 
exercise timing hypothesis. As such, Pierce and co-workers (Pierce et al., 2011b) reported 
that there was no effect of aerobic exercise training on brachial artery flow mediated 
dilation at any time after menopause. Moreover, data on lifelong trained late 
menopausal women indicate that forearm vascular function is similar to that of age-matched 
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sedentary women (Pierce et al., 2011b; Santos-Parker et al., 2017). Leg vascular function, on 
the other hand, as assessed by femoral arterial infusion of acetylcholine, is better 
in lifelong trained late post-menopausal women compared to sedentary age-
matched women (L. Gliemann & Y. Hellsten, unpublished findings, fig. 2). Yet, similar to 
our previous finding in men (Nyberg et al. 2014), leg vascular function in the life-long 
trained women is impaired compared to that of younger women pointing at a non-trainable 
age-induced impairment in both men and women (fig. 2). Therefore, the sex-specific lack of 
vascular improvement in life-long trained women observed by Santos Parker et al. (Santos-
Parker et al., 2017) may primarily be related to the remote effect of leg training on the arm 
vasculature. As previous studies have suggested that the effect of leg training on brachial 
artery flow mediated dilation is associated with shear stress (Birk et al. 2012) one underlying 
mechanism could be that shear stress sensing is impaired in postmenopausal women. 
 
Evidence for an effect of exercise training, or lack her of, on cardiovascular health in women 
is still limited. Only a few laboratories have published on this important aspect of normal 
human aging and it should be emphasized that the methodologies used for evaluating 
vascular function in post-menopausal women differ between studies. As an example of a 
pivotal difference, our laboratory measures vascular function in the leg and uses intra-arterial 
infusion of vasoactive compounds while other laboratories use the arm as the experimental 
limb and use the non-invasive flow mediated dilation technique to evaluate vascular function. 
Such discrepancies may explain some of the differences in findings between studies. One 
aspect also worth emphasizing is that improvements after exercise training are generally 
observed in studies where vascular function is assessed in the leg which most likely reflects 
that improvements are most prominent in the trained limbs. 
If the exercise timing hypothesis holds true, it will provide a basis for important 
recommendations to women with regard to the beneficial effects of physical activity through 
the ages. The menopausal transition can have a severe impact on health status and wellbeing 
in general, and women will benefit from clear recommendations on whether there may be an 
advantage to initiate a physically active life-style before or at menopause rather than later on 
in life. However, it should be strongly emphasized that this does not mean that it is too late to 
begin being more physically active later in life, physical activity is beneficial at all ages. 
Likewise, although significant changes in vascular function may be difficult to achieve in late 
post-menopause, exercise training still provides a plethora of health benefits.  
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Figures and legends 
Figure 1. Activation of estrogen response element (ERE) and eNOS by estrogen (17 estradiol) and 
muscle contraction. ERE can be activated by muscle contraction via the MAPK - PGC1 - estrogen 
related receptor- (ERR) pathway. This pathway leads to genomic upregulation of endothelial nitric 
oxide synthase (eNOS) which may improve regulation of vascular function by increasing NO 
bioavailability. Estrogens activates ERE directly via estrogen receptors (ER) activation and may also 
lead to improved vascular regulation via increased eNOS expression and activate eNOS by 
phosphorylation of residue serine1177 via Phosphoinositide 3-kinase (PI3K) – Protein kinase B (Akt) 
pathway. Both exercise and estrogen also phosphorylate eNOS via PGC1 and G-protein coupled 
estrogen receptor 1 (GPER1), respectively. Collectively, both estrogen and exercise can reduce 
plaque formation and improve vascular function and arterial remodeling. The interaction between 
estrogens and exercise, in the pre-, recent post- and late post-menopausal phase is not fully 
understood.  
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Figure 2. Changes in vascular conductance induced by femoral arterial acetylcholine infusion 
(100 g  min-1  L leg volume-1) in sedentary pre-menopausal (n=20), recent post-
menopausal women (n=16, 4 years since last menstruation), late post-menopausal women 
(n=11, 9 years since last menstruation and n=10, 17 years since last menstruation) and 
lifelong trained post-menopausal women (n=12, 14 years since last menstruation). Age 
(years) and fitness level (VO2max; ml O2  kg
-1
  min-1) are presented in the upper box. Data are 
mean  SE and combined from Nyberg et al 2016 and unpublished observations. The 
statistical analysis was run R-studio with a linear mixed model. * lower than pre meno; # 
lower than 3y post; § higher than 9y and 17y post. Note the marked decrease in vascular 
response to acetylcholine infusion at 9y and 17y post menopause and that this decline is 
attenuated to some extent, but not fully, in the lifelong trained group. 
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Figure 3. Protein expression of estrogen related receptor  (ERR) as function of time after 
menopause in skeletal muscle homogenates from sedentary pre-menopausal and post-
menopausal women. Data are mean  SE and combined from Nyberg et al 2016 (open 
circles) and unpublished observations (closed circles). 
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Abstract figure. Exercise training initiates cellular signals that includes activation of 
estrogen response element which leads to increased expression and activation of 
endothelial nitric oxide synthase (eNOS). This improves vascular tone, increases plaque 
removal and arterial remodeling resulting in improved vascular function. Estrogen 
induces similar improvements to the vascular system and the exercise timing hypothesis 
suggest that exercise induced improvements to the vasculature is easier achieved before 
the menopausal transition when both estrogen and exercise can activate these pathways 
compared to after menopause. 
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